Concepedia

J. Jean Cui

JJ

2

Publications

59

Citations

2

H-Index

2013

Active since

Affiliations

Turing Institute(Current)

J. Jean Cui is an author at Turing Institute specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2013–2020

2

Publications

2

Lessons from (<i>S</i>)-6-(1-(6-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an Inhibitor of Receptor Tyrosine Kinase c-Met with High Protein Kinase Selectivity but Broad Phosphodiesterase Family Inhibition Leading to Myocardial Degeneration in Rats

J. Jean Cui, Hong Shen, Michelle Tran‐Dubé et al. · Journal of Medicinal Chemistry · 2013 · 39 citations · Full text

, , +22

Abstract 5226: TPX-0131: A next generation macrocyclic ALK inhibitor that overcomes ALK resistant mutations refractory to current approved ALK inhibitors

J. Jean Cui, Evan Rogers, Dayong Zhai et al. · Cancer Research · 2020 · 20 citations

, , +23

Rows per page

1–2 of 2